Drugs for the Treatment of Muscle Atrophy
Muscle mass is maintained through an interplay between anabolic and catabolic pathways. The ubiquitin-proteasome system plays an important role in the proteolysis progress during skeletal muscle atrophy which can be blocked by some proteasome inhibitors. But few studies have demonstrated the ability...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/73162 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Drugs for the Treatment of Muscle Atrophy
- Nutritional Approaches for Attenuating Muscle Atrophy
- A Review on the Mechanisms of Stroke-Induced Muscle Atrophy
- Molecular Evidence: EA May Inhibit the Muscle Atrophy
- Prevention of Skeletal Muscle Wasting: Disuse Atrophy and Sarcopenia
- Revisiting Skeletal Muscle Atrophy: Links between Copper Overload, Cuproptosis, and Muscle Atropy
- Spinal Muscular Atrophy